Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 853 for “"Kinase Inhibitor"”.
-
SCRIBBLE: A POTENTIAL DUAL KINASE INHIBITOR
Extracellular signal-regulated kinases (ERKs) modulate cellular activities in response to extracellular stimuli and play important biological roles. Thus, perturbed kinase pathways induce pathological conditions, such as tumor development. Rit, a novel member of the Ras family GTPases, activase …
-
SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA
Tyrosine kinase inhibitors (TKIs) which inhibit BCR-ABL1 kinase activity control but do not cure chronic myeloid leukemia (CML), suggesting the existence of BCR-ABL1-independent factors that preserve CML leukemic stem cells (LSCs). Using RNA-sequencing, we identified differentially expressed …
-
Identifying Metabolic Vulnerabilities Induced by the ABL Kinase Inhibitor Asciminib
<p>The successful drugging of the ABL family kinases represents one of the major therapeutic advances in modern oncology. In chronic myeloid leukemia, inhibition of the BCR-ABL1 fusion oncoprotein transformed a previously lethal disease into one that can often be managed for many years, if not …
-
Functional Motifs in SIAMESE, a Plant Cyclin-Dependent Kinase Inhibitor
… and hence have been suggested to be CDK inhibitors. In this study, I have investigated the exact role of SIM and SMRs and their evolutionarily conserved function throughout land plant evolution. Using split luciferase complementation (SLC), I have shown that both SIM and a distantly …
-
Regulation of the cyclin dependent kinase inhibitor p27 in glioblastoma
… malignant brain tumour. The cyclin dependant kinase inhibitor p27 is commonly inactivated in this and many other cancers. p27 is an important negative regulator of the cell cycle which acts by inhibiting cyclinE/cdk2 and cyclinA/cdk2 complexes. We identify PKCiota, a pro-proliferative kinase …
-
Phosphotidylinositol-3-Kinase Inhibitor (PIK75) Enhanced Nnanosystems For Anticancer Drug Delivery
… PIK75 is a potent and specific PI3K p110α inhibitor with poor water solubility which has limited its preclinical investigation. The aim of this study was to design and evaluate formulation systems of PIK75. Two nano formulation systems were investigated for the delivery of PIK75 namely …
-
Regulation und Funktion des Raf Kinase Inhibitor Proteins unter ischämischen Bedingungen
Das Raf Kinase Inhibitor Protein (RKIP) ist ein vielseitiger Regulator zellulärer Prozesse und vermittelt seine Effekte über die Hemmung verschiedener Singalwege. Im unphosphorylierten Zustand inhibiert es beispielsweise die Kinase Raf-1, wodurch die Aktivierung der Raf/MEK/ERK1/2-Kaskade …
-
Investigating mechanisms of acquired resistance to AT13148, an AGC kinase inhibitor
… a member of the AGC family of serine/threonine kinases, is a key signalling node within the PAM pathway, and as such, an attractive therapeutic target for the treatment of cancer. AT13148 is an ATP-competitive inhibitor of AKT, currently in phase 1 clinical trial, which also potently inhibits …
-
Off-target identification for a multitarget kinase inhibitor by Chemical Proteomics
… approach for the identification of non-protein kinase off-targets of the multitarget protein kinase inhibitor C1 is presented. Two different compound immobilization routes were applied in order to identify off-targets interacting with distinct compound moieties. Furthermore, a soluble mimic of …
-
ACTIVITY OF A NOVEL LYN KINASE INHIBITOR IN TRIPLE NEGATIVE BREAST CANCER
Src Family Kinases (SFKs) play pivotal roles in cell invasion, proliferation, and angiogenesis. Aberrant activation of the SFKs contributes to various oncogenic pathways in cancer. Interestingly, of the various breast cancer subtypes, the Triple Negative Breast Cancer (TNBC) is most sensitive to …
-
Transcriptomic consequences of RNA processing disruption via a novel CDC-like kinase inhibitor
… compound that inhibits the CDC-like family of kinases, which regulate key splicing factors. Although splicing inhibitors have already been published, their effects on the RNA splicing landscape have not been systematically described. The creation of a novel splicing inhibitor presents the …
-
Radiosensitization of Head & Neck Carcinoma Cells by Linifanib, A Receptor Tyrosine Kinase Inhibitor
… Linifanib (ABT-869), a multi-receptor tyrosine kinase inhibitor of VEGF and platelet derived growth factor (PDGF) receptor families, on radio-sensitization of HNSCC. The results show that Linifanib (ABT-869) can induce an antitumor effect and radio-sensitize HNSCC cells via inhibition of STAT3 …
-
Characterising EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines
Tyrosine kinase inhibitors (TKIs) that target the human epidermal growth factor receptor (EGFR) are targeted therapies used in the clinic for treating non-small cell lung cancer (NSCLC) harbouring activating mutations in the EGFR protein. As a targeted therapy, EGFR TKIs offer several benefits over …
-
Tyrosine kinase inhibitor toxicity in chronic myeloid leukemia: it is all about energy
Contains fulltext : 311845.pdf (Publisher’s version ) (Open Access)
Page 1 of 43